Abstract
The world’s status quo on recreational drugs has dramatically changed in recent years due to the rapid emergence of new psychoactive substances (NPS), represented by new narcotic or psychotropic drugs, in pure form or in preparation, which are not controlled by international conventions, but that may pose a public health threat comparable with that posed by substances listed in these conventions. These NPS, also known as ‘legal highs’ or ‘smart drugs’, are typically sold via Internet or ‘smartshops’ as legal alternatives to controlled substances, being announced as ‘bath salts’ and ‘plant feeders’ and is often sought after for consumption especially among young people. Although NPS have the biased reputation of being safe, the vast majority has hitherto not been tested and several fatal cases have been reported, namely for synthetic cathinones, with pathological patterns comparable with amphetamines. Additionally, the unprecedented speed of appearance and distribution of the NPS worldwide brings technical difficulties in the development of analytical procedures and risk assessment in real time. In this study, 27 products commercialized as ‘plant feeders’ were chemically characterized by gas chromatography–mass spectrometry and nuclear magnetic resonance spectroscopy. It was also evaluated, for the first time, the in vitro hepatotoxic effects of individual synthetic cathinones, namely methylone, pentedrone, 4-methylethcathinone (4-MEC) and 3,4-methylenedioxypyrovalerone (MDPV). Two commercial mixtures (‘Bloom’ and ‘Blow’) containing mainly cathinone derivatives were also tested, and 3,4-methylenedioxymethamphetamine (MDMA) was used as the reference drug. The study allowed the identification of 19 compounds, showing that synthetic cathinones are the main active compounds present in these products. Qualitative and quantitative variability was found in products sold with the same trade name in matching or different ‘smartshops’. In the toxicity studies performed in primary cultured rat hepatocytes, pentedrone and MDPV proved to be the most potent individual agents, with EC50 values of 0.664 and 0.742 mM, respectively, followed by MDMA (EC50 = 0.754 mM). 4-MEC and methylone were the least potent substances, with EC50 values significantly higher (1.29 and 1.18 mM, respectively; p < 0.05 vs. MDMA). ‘Bloom’ and ‘Blow’ showed hepatotoxic effects similar to MDMA (EC50 = 0.788 and 0.870 mM, respectively), with cathinones present in these mixtures contributing additively to the overall toxicological effect. Our results show a miscellany of psychoactive compounds present in ‘legal high’ products with evident hepatotoxic effects. These data contribute to increase the awareness on the real composition of ‘legal high’ packages and unveil the health risks posed by NPS.
Similar content being viewed by others
References
Archer RP (2009) Fluoromethcathinone, a new substance of abuse. Forensic Sci Int 185(1–3):10–20. doi:10.1016/j.forsciint.2008.11.013
Arunotayanun W, Gibbons S (2012) Natural product ‘legal highs’. Nat Prod Rep 29(11):1304–1316. doi:10.1039/c2np20068f
Baron M, Elie M, Elie L (2011) An analysis of legal highs: do they contain what it says on the tin? Drug Test Anal 3(9):576–581. doi:10.1002/dta.274
Baumann MH, Partilla JS, Lehner KR (2013) Psychoactive “bath salts”: not so soothing. Eur J Pharmacol 698(1–3):1–5. doi:10.1016/j.ejphar.2012.11.020
Borek HA, Holstege CP (2012) Hyperthermia and multiorgan failure after abuse of “bath salts” containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med 60(1):103–105. doi:10.1016/j.annemergmed.2012.01.005
Boulanger-Gobeil C, St-Onge M, Laliberté M, Auger PL (2012) Seizures and hyponatremia related to ethcathinone and methylone poisoning. J Med Toxicol 8:59–61. doi:10.1007/s13181-01-0159-1
Brandt SD, Sumnall HR, Measham F, Cole J (2010) Analyses of second-generation ‘legal highs’ in the UK: initial findings. Drug Test Anal 2(8):377–382. doi:10.1002/dta.155
Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (2011) Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones. Drug Test Anal 3:569–575. doi:10.1002/dta.204
Camilleri A, Johnston MR, Brennan M, Davis S, Caldicott DGE (2010) Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci Int 197(1–3):59–66. doi:10.1016/j.forsciint.2009.12.048
Carbone PN, Carbone DL, Carstairs SD, Luzi SA (2013) Sudden cardiac death associated with methylone use. Am J Forensic Med Pathol 34(1):26–28. doi:10.1097/PAF.0b013e31827ab5da
Carvalho M, Milhazes N, Remiao F, Borges F, Fernandes E, Amado F, Monks T, Carvalho F, Bastos ML (2004) Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol 78(1):16–24. doi:10.1007/s00204-003-0510-7
Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F (2010) Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol 11(5):476–495
Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remião F, Carvalho F, Bastos ML (2012) Toxicity of amphetamines: an update. Arch Toxicol 86(8):1167–1231. doi:10.1007/s00204-012-0815-5
Casale JF, Hays PA (2011) The characterization of 5- and 6-(2-Aminopropyl)benzofuran-2,3-dihydrobenzofuran. Microgram J8(2):62–74
Casale JF, Hays PA (2012) The characterization of 6-(2-Aminopropyl)benzofuran differentiation from its 4-, 5-, and 7-positional analogues. Microgram J9(2):61–74
Coppola M, Mondola R (2012a) Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”. Toxicol Lett 211(2):144–149. doi:10.1016/j.toxlet.2012.03.009
Coppola M, Mondola R (2012b) 3,4-Methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 208(1):12–15. doi:10.1016/j.toxlet.2011.10.002
Daeid NN, Savage KA, Ramsay D, Holland C, Sutcliffe OB (2014) Development of gas chromatography–mass spectrometry (GC–MS) and other rapid screening methods for the analysis of 16 ‘legal highs’ cathinone derivatives. Sci Justice 54(1):22–31. doi:10.1016/j.scijus.2013.08.004
Davies S, Wood D, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI (2010) Purchasing ‘legal highs’ on the internet—is there consistency in what you get? QJM 103(7):489–493. doi:10.1093/qjmed/hcq056
Davies S, Lee T, Ramsey J, Dargan PI, Wood DM (2012) Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances). Eur J Clin Pharmacol 68(4):435–439. doi:10.1007/s00228-011-1144-y
Davis S, Rands-Trevor K, Boyd S, Edirisinghe M (2012) The characterisation of two halogenated cathinone analogues: 3,5-difluoromethcathinone and 3,5-dichloromethcathinone. Forensic Sci Int 217(1–3):139–145. doi:10.1016/j.forsciint.2011.10.042
De Letter EA, Piette MH, Lambert WE, Cordonnier JA (2006) Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976–2004. Med Sci Law 46(1):37–65
Dias da Silva D, Carmo H, Silva E (2013a) The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines? Arch Toxicol 87(1):111–122. doi:10.1007/s00204-012-0929-9
Dias da Silva D, Silva E, Carmo H (2013b) Cytotoxic effects of amphetamine mixtures in primary hepatocytes are severely aggravated under hyperthermic conditions. Toxicol In Vitro 27(6):1670–1678. doi:10.1016/j.tiv.2013.04.010
Elie M, Elie L, Baron M (2013) Keeping pace with NPS releases: fast GC–MS screening of legal highs products. Drug Test Anal 5(5):281–290. doi:10.1002/dta.1434
Elliott SP, Brandt SD, Freeman S, Archer RP (2012) AMT (3-(2-aminopropyl)indole) and 5-IT (5-/2-aminopropyl)indole): an analytical challenge and implications for forensic analysis. Drug Test Anal 5(3):196–202. doi:10.1002/dta.1420
EMCDDA (2012) The EMCDDA annual report 2012: the state of the drugs problem in Europe. Eur Surveill. doi:10.2810/64775. http://www.emcdda.europa.eu/
EMCDDA (2013) European drug report 2013: trends and developments. Eur Surveill. http://www.emcdda.europa.eu/edr2013
Fröhlich S, Lambe E, O’Dea J (2011) Acute liver failure following recreational use of psychotropic “head shops” compounds. Ir J Med Sci 180(1):263–264. doi:10.1007/s11845-010-0636-6
Garcia-Repetto R, Moreno E, Soriano T, Jurado C, Giménez MP, Menéndez M (2003) Tissue concentrations of MDMA and its metabolites MDA in three fatal cases of overdose. Forensic Sci Int 135(2):110–114
Garrett G, Sweeney M (2010) The serotonin syndrome as a result of mephedrone toxicity. BMJ Case Rep 2010:1–5. doi:10.1136/bcr.04.2010.2925
James D, Adams RD, Spears R, Cooper G, Lupton DJ, Thompson JP, Thomas SH (2011) Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service. Emerg Med J 28(8):686–689. doi:10.1136/emj.2010.096636
Jankovics P, Váradi A, Tölgyes L, Lohner S, Németh-Palotás J, Kőszegi-Szalai H (2011) Identification and characterization of the new designer drug 4′-methylethcathinone (4-MEC) and elaboration of a novel liquid chromatography–tandem mass spectrometry (LC–MS/MS) screening method for seven different methcathinone analogs. Forensic Sci Int 210(1–3):213–220. doi:10.1016/j.forsciint.2011.03.019
Kamata HT, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa M, Katagi M, Tsuchihashi H (2006) Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica Fate Foreign Compd Biol Syst 36(8):709–723. doi:10.1080/00498250600780191
Kavanagh P, O´Brien J, Fox J, O´Donnell C, Christie R, Power JD, McDermott SD (2012) The analysis of cathinones. Part 3. Synthesis and characterization of 2,3-methylenedioxy substituted cathinones. Forensic Sci Int 216(1–3):19–28. doi:10.1016/j.forscint.2011.08.011
Kelly JP (2011) Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 3(7–8):439–453. doi:10.1002/dta.313
Khreit OI, Grant MH, Zhang T, Henderson C, Watson DG, Sutcliffe OB (2013) Elucidation of the phase I and phase II metabolic pathways of (±)-4′-methylmethcathinone (4-MMC) and (±)-4′-(trifluoromethyl)methcathinone (4-TFMMC) in rat liver hepatocytes using LC–MS and LC–MS(2). J Pharm Biomed Anal 72:177–185. doi:10.1016/j.jpba.2012.08.015
Kortenkamp A (2007) Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect 115(Suppl 1):98–105. doi:10.1289/ehp.9357
Kovacs K, Toth AR, Kereszty EM (2012) A new designer drug: methylone related death. Orv Hetil 153(7):271–276. doi:10.1556/OH.2012.29310
Leffler AM, Smith PB, Armas A, Dorman F (2014) The analytical investigation of synthetic street drugs containing cathinone analogs. Forensic Sci Int 234:50–56. doi:10.1016/j.forsciint.2013.08.021
Levine M, Levitan R, Skolnik A (2013) Compartment syndrome after “bath salts” use: a case series. Ann Emerg Med 61(4):480–483. doi:10.1016/j.annemergmed.2012.11.021
Locos O, Reynolds D (2012) The characterization of 3,4-dimethylmethacahinone (3,4-DMMC). J Forensic Sci 57(5):1303–1306. doi:10.1111/j.556-4029.2012.02142
Lusthof KJ, Oosting R, Maes A, Verschraagen M, Dijkhuizen A, Sprong AG (2011) A case of extreme agitation and death after the use of mephedrone in The Netherlands. Forensic Sci Int 206(1–3):e93–e95. doi:10.1016/j.forsciint.2010.12.014
Maheux CR, Copeland CR (2011) Chemical analysis of two new designer drugs: buphedrone and pentedrone. Drug Test Anal 4(1):17–23. doi:10.1002/dta.385
McDermott SD, Power JD, Kavaganagh P, O’Brien J (2011) The analysis of substituted cathinones. Part 2: an investigation into the phenylacetone based isomers of 4-methylmethcathinone and N-ethylcathinone. Forensic Sci Int 212(1–3):13–21. doi:10.1016/j.forscint.2011.06.030M
Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high-resolution MS and its detectability in urine by GC–MS. J Mass Spectrom JMS 45(12):1426–1442. doi:10.1002/jms.1859
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63
Murray BL, Murphy CM, Beuhler MC (2012) Death following recreational use of designer drug “bath salts” containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol 8(1):69–75. doi:10.1007/s13181-011-0196-9
Payne J, Rajapakse N, Wilkins M, Kortenkamp A (2000) Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 108(10):983–987
Payne J, Scholze M, Kortenkamp A (2001) Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ Health Perspect 109(4):391–397
Pearson J, Hargraves T, Hair L, Massucci C, Frazee C, Garg U, Pietak B (2012) Three fatal intoxications due to methylone. J Anal Toxicol 36(6):444–451. doi:10.1093/jat/bks043
Penders TM, Gestring RE, Vilensky DA (2012) Excited delirium following use of synthetic cathinones (bath salts). Gen Hosp Psychiatry 34(6):647–650. doi:10.1016/j.genhosppsych.2012.06.005
Portuguese Government (2013) Decreto-Lei n.º 54/2013. Diário da República 75
Prosser JM, Nelson LS (2012) The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8(1):33–42. doi:10.1007/s13181-011-0193-z
Regunath H, Ariyamuthu VK, Dalal P, Misra M (2012) Bath salt intoxication causing acute kidney injury requiring hemodialysis. Hemodial Int Int Sympos Home Hemodial 16(Suppl 1):S47–S49. doi:10.1111/j.1542-4758.2012.00750.x
Research IFLA (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington
Rojek S, Klys M, Strona M, Maciów M, Kula K (2012) “Legal highs”—toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration. Forensic Sci Int 222(1–3):e1–e6. doi:10.1016/j.forsciint.2012.04.034
Rösner P, Quednow B, Girreser U, Junge T (2005) Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substances analogues (designer drugs). Forensic Sci Int 148(2–3):143–146
Schifano F, Corkery J, Ghodse AH (2012) Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, “meow meow”) in the United Kingdom. J Clin Psychopharmacol 32(5):710–714. doi:10.1097/JCP.0b013e318266c70c
Scholze M, Boedeker W, Faust M, Backhaus T, Altenburger R, Grimme LH (2001) A general best-fit method for concentration–response curves and the estimation of low-effect concentrations. Environ Toxicol Chem 20(2):448–457
Silva E, Rajapakse N, Kortenkamp A (2002) Something from “nothing”-eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol 36(8):1751–1756
Silva DG, de Pinho PG, Pontes H, Ferreira L, Branco P, Remião F, Carvalho F, Bastos ML, Carmo H (2010) Gas chromatography–ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci 878(9–10):815–822. doi:10.1016/j.jchromb.2010.01.042
Silva DD, Silva E, Carvalho F, Carmo H (2013a) Mixtures of 3,4-methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non-cytotoxic concentrations. J Appl Toxicol. doi:10.1002/jat.2885
Silva DD, Silva E, Carmo H (2013b) Combination effects of amphetamines under hyperthermia—the role played by oxidative stress. J Appl Toxicol. doi:10.1002/jat.2889
Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in United States. Clin Toxicol 49(6):499–505. doi:10.3109/15563650.2011.590812
Valente MJ, Guedes de Pinho P, Bastos ML, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Arch Toxicol 88(1):15–45. doi:10.1007/s00204-013-1163-9
Warrick BJ, Wilson J, Hedge M, Freeman S, Leonard K, Aaron C (2012) Lethal serotonin syndrome after methylone and butylone ingestion. J Med Toxicol 8(1):65–68. doi:10.1007/s13181-011-0199-6
Westphal F, Junge T, Girreser U, Greibl W, Doering C (2012) Mass, NMR and IR spectroscopic characterization of pentedrone and pentylone and identification of their isocathinone by-products. Forensic Sci Int 217(1–3):157–167. doi:10.1016/j.forsciint.2011.10.45
Wikstrom M, Thelander G, Nystrom I, Kronstrand R (2010) Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). J Anal Toxicol 34(9):594–598. doi:10.1093/jat/34.9.594
Wood DM, Davies S, Greene SL, Button J, Holt DW, Ramsey J, Dargan PI (2010) Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol 48(9):924–927. doi:10.3109/15563650.2010.531021
Zaitsu K, Katagi M, Kamata HT, Kamata T, Shima N, Miki A, Tsuchihashi H, Mori Y (2009) Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic Sci Int 188(1–3):131–139. doi:10.1016/j.forsciint.2009.04.001
Zuba D, Byrska B (2013) Prevalence and co-existence of active components of ‘legal highs’. Drug Test Anal 5(6):420–429. doi:10.1002/dta.1365
Zukiewicz-Sobczak W, Zwolinski J, Chmielewska-Badora J, Krasowska E, Piatek J, Sobczak P, Wojtyła A, Fornal E, Kuczumow A, Biliński P (2012) Analysis of psychoactive and intoxicating substances in legal highs. Ann Agric Environ Med 19(2):309–314
Acknowledgments
The authors thank the Fundação para a Ciência e a Tecnologia (FCT) for financial support through Projects PestC/EQB/LA0006/2011 and Pest-OE/QUI/UI0612/2013. Maria João Valente thank FCT for her PhD Grant (SFRH/BD/89879/2012) and Diana Dias da Silva thank SAESCTN-PIIC&DT/1/2011-Norte-07-0124-FEDER-000067 financial support.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Araújo, A.M., Valente, M.J., Carvalho, M. et al. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones. Arch Toxicol 89, 757–771 (2015). https://doi.org/10.1007/s00204-014-1278-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-014-1278-7